Health Compendium's Blog



Person looking tired and fatigued, representing idiopathic hypersomnia symptoms in Australia and excessive daytime sleepiness.
Australia

Idiopathic Hypersomnia in Australia: Why Diagnosis and Treatment Are So Hard to Access

Idiopathic hypersomnia (IH) is a chronic neurological disorder causing overwhelming daytime sleepiness and severe sleep inertia, unrelated to how much sleep someone gets. In Australia, patients face major barriers: low awareness among GPs, no distinct diagnostic code, long public-system wait times for sleep studies, and zero TGA-approved medications, meaning all treatment is off-label and PBS coverage is inconsistent. Lifestyle changes rarely control symptoms on their own. Patients can push for change by advocating with the TGA/PBAC, connecting with groups like the Sleep Health Foundation and Hypersomnia Foundation, and joining research studies.

Read More »
Man sitting with his eyes closed, looking exhausted, representing excessive daytime sleepiness caused by idiopathic hypersomnia
Idiopathic Hypersomnia

The Invisible Struggle & Flumazenil in Canada in 2026: Unveiling the Challenges of Idiopathic Hypersomnia Care in the Canadian Healthcare System

The TLDR. The Canadian healthcare system fails idiopathic hypersomnia patients through lack of awareness, limited sleep testing access and absence of Health Canada-approved medications. Nevertheless, informed sleep specialists can provide effective management through carefully selected off-label treatments such as flumazenil. Our forthcoming article will examine flumazenil as a potential option for patients who haven’t responded adequately to conventional therapies.

Read More »
Collage of a young man showing signs of chronic exhaustion, including him asleep at a desk, lying in bed during daytime hours, and rubbing his eyes with a tired expression.
Idiopathic Hypersomnia

Overcoming Idiopathic Hypersomnia: How Flumazenil Helped Stuart Kennedy Reclaim His Life

The TLDR: Stuart Kennedy of Canberra, Australia, spent years trapped by idiopathic hypersomnia (IH), a rare and poorly understood sleep disorder that left him sleeping up to 18 hours a day. After conventional stimulants failed him, his family tracked down an experimental treatment, flumazenil, that slowly, rather than instantly, gave him his life back. He clawed his way through missed schooling, rebuilt his academic standing, and eventually earned a place studying software engineering at the University of Canberra. His story is a window into an under-recognized illness, a still-emerging treatment, and what it takes for a family to refuse to give up.

Read More »

Now Shipping - Contact Us